National Space Biomedical Research Institute Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00968344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now